MOTS-c Mitochondrial Peptide

Among the specialty reagents that laboratories request from peptide suppliers, the MOTS-c mitochondrial peptide stands out because of where it comes from: it is encoded in mitochondrial DNA rather than in the nuclear genome, a distinction that makes it one of the more unusual entries in a research catalog. That origin story matters for more than curiosity — it shapes how the compound is classified, how the literature describes it, and it raises sourcing questions that are specific to this molecule. This guide covers what the MOTS-c mitochondrial peptide actually is, what published studies report, how to verify purity and identity on a certificate of analysis, and how to handle the vials correctly once they reach the bench. It is written for laboratories buying research peptides for legitimate study purposes, in the practical spirit of a methods-driven buyer, not a marketing summary.

What the MOTS-c Mitochondrial Peptide Is

MOTS-c is a short peptide derived from the open reading frame of the mitochondrial genome. In the laboratory context that matters here, it arrives as a synthetic, lyophilized research reagent, identical in sequence to the bioactive form described in the literature. The molecule is not a fragment of a larger nuclear-encoded precursor in the usual sense; its mitochondrial origin is exactly what earns the peptide its own place in the literature and in the catalog.

The compound circulates in listings under a small set of names, and buyers should expect one of them to be an all-caps sequence shorthand derived from its amino acid makeup. The full name “MOTS-c,” the expanded descriptor, and the sequence notation all refer to the same molecule, and a certificate that ties those labels together is the first document a careful laboratory asks for. Suppliers that stock the material typically offer it as a lyophilized powder in sealed research vials with an HPLC purity statement and a batch certificate that documents identity by mass spectrometry.

It is also worth knowing where the compound sits in the market. MOTS-c is a specialist molecule with a modest publication record, which means the supply chain is small, the number of vendors is limited, and the documentation standards vary noticeably between suppliers. Small-market peptides reward buyers who check the paperwork before they check out, and this compound is a textbook example of that rule. The background sections below explain what to look for at each step.

Why the Mitochondrial Origin Matters for Research

The mitochondrial origin of the peptide is not a footnote; it shapes the way researchers frame hypotheses. Because the sequence comes from mitochondrial DNA, studies tend to discuss the compound in the context of mitochondrial function, metabolic signaling, and cellular stress responses, rather than in the context of the nuclear-encoded peptides that dominate most catalogs. A laboratory designing an experiment around the compound should therefore build the background section around mitochondrial biology, because that is where the supporting literature lives.

The practical consequence for protocol design is straightforward. If the study hypothesis concerns metabolism or mitochondrial signaling pathways, the peptide literature can support it directly. If the hypothesis reaches into areas where the family has only indirect coverage, the background section becomes harder to defend and reviewers will notice. Framing the question at the level where the primary literature actually reports results is the single most effective way to keep the project defensible from the abstract to the references.

How the MOTS-c Mitochondrial Peptide Is Studied in the Laboratory

Published work on the compound concentrates on cell-culture investigations of metabolic signaling, including how cells respond to stress, how metabolic pathways shift under different conditions, and how the peptide influences signaling that touches on mitochondrial function. Most studies are in vitro models, which means the reagent is discussed in terms of concentration, exposure time, and cell model rather than in terms of whole-organism outcomes. That is a useful thing to know before designing a study, because it sets realistic expectations for what the literature can and cannot support.

For a laboratory, the recurring design choices are the cell model, the dosing schedule, and the control compounds. Concentration-response work is the norm, so a buyer should plan for a range of doses rather than a single concentration, and the exact concentration used in a given paper depends on the model and the preparation routine, which are rarely transferable without checking the methods section. Literature values are a starting point for dose finding, not a substitute for a curve run in the laboratory’s own system.

Control design also deserves care. Because the peptide is small and synthetic, common controls include vehicle-only conditions, sequence-scrambled or unrelated peptides, and matched batches at different purities. A study that runs a vehicle control but no unrelated-peptide control leaves room for a critic to ask whether the observed effect is specific to the sequence; the extra control is cheap and it closes that argument before it starts. The decision is best made at the design stage, while the reagent order can still be adjusted.

What the Published Literature Actually Covers

The citation trail for the compound runs through mitochondrial peptide research: metabolic signaling studies, stress-response models, and papers that compare small mitochondrial peptides with each other. The primary literature is small but real, and it clusters in cell-biology and metabolic journals rather than in clinical medicine. A background search that combines the peptide name with mitochondrial biology terms gives the broadest picture in the fewest queries, and most of the relevant papers will surface in those two passes.

Useful starting points in the literature indexes include:

• Primary compound coverage: PubMed index for MOTS-c
• Broader mitochondrial peptide background: PubMed index for mitochondrial peptide metabolic signaling studies

When scanning these indexes, note the study-design details rather than the titles: the cell model, the compound source, the stated purity, and the preparation method. Papers that describe their reagents carefully are the most useful comparators, because they give a reader enough detail to reproduce the conditions. Publication volume alone is evidence of history, not evidence of suitability for a particular protocol, and the two questions should never be confused in a background section.

How the Literature Compares with Related Mitochondrial Peptides

Readers of this literature will quickly encounter other short peptides discussed in mitochondrial research, most prominently the compound often abbreviated SS-31. The two molecules are different reagents: they have different sequences, different origins, and separate publication trails, even though they sometimes appear side by side in the same review articles or catalog sections. A laboratory should never substitute one for the other, and the certificate is the only reliable way to confirm which molecule is actually in the vial. If a listing or a paper seems to blend the two, treat that as a documentation problem, because for the bench the distinction is absolute.

Purity, Identity and the Certificate of Analysis

The certificate of analysis is where sourcing discipline is won or lost for this compound. Because the peptide is short and synthetic, a linear synthesis byproduct can share much of the mass logic of the target while behaving differently in an assay, and a bare purity percentage cannot distinguish the target from a close synthesis side product. Identity confirmation by mass spectrometry closes that gap, which is why it should be a minimum expectation alongside the HPLC purity number. The site’s guide to reading a certificate of analysis walks through each line, and the same evaluation logic applies to every reagent in the catalog.

Before ordering, a laboratory should ask for the batch certificate and check four things. First, the HPLC purity percentage should be reported for the exact batch being supplied, not as a typical range. Second, the identity line should name the peptide and the analytical method, ideally mass spectrometry with a measured molecular weight. Third, the batch number on the certificate should match the batch number printed on the vial label. Fourth, the peptide form, including salt form and counterion if applicable, should be stated, because listings vary between vendors and the salt changes the dosing math.

For laboratories that want an independent second opinion, third-party lab reports add confidence. Sending a small sample for an independent HPLC run is inexpensive relative to the cost of a compromised experiment, and it converts a vendor claim into measured data that can be archived with the batch records. The lab reports page on the site explains how independent analytical testing supports the compounds supplied to laboratories, and the same idea generalizes to any specialty reagent.

Reconstitution and Storage for Laboratory Vials

Handling the reagent follows the standard lyophilized-peptide routine, and deviations from that routine are where most bench problems start. Sealed vials should stay refrigerated, dry, and away from light until reconstitution. When the time comes, bacteriostatic water is the typical solvent of choice, added down the inner wall of the vial rather than directly onto the lyophilized cake. Swirling, not shaking, dissolves the material without generating foam that can denature or trap the peptide.

After reconstitution, the solution should be refrigerated and used promptly. Freeze-thaw cycling is the enemy of peptide solutions: each cycle can encourage aggregation and reduce the effective concentration, so wherever the protocol allows, aliquot the reconstituted solution into single-use tubes and label each tube with the compound, the batch number, the date, and the final concentration. The complete routine is described in the site’s reconstitution and storage guide, and it applies without modification to short peptides of this class.

What to Record on the Label

Documentation discipline pays off at the end of a study. The minimum label set is the compound name, the batch number, the reconstitution date, and the final concentration. If the protocol demands reproducibility, the exact volume of solvent added should be recorded as well, because a difference of a few tenths of a milliliter changes the concentration enough to matter in a sensitive assay. Writing these four fields on every tube before the experiment starts removes guesswork from later troubleshooting sessions and keeps the paper trail connected from the arrival log to the plate readers.

Sourcing Considerations for a Small-Market Peptide

Selection criteria for a supplier should be the same criteria a laboratory would apply to any specialty reagent. Transparent batch documentation, a published certificate of analysis, clear research-use labeling, and straightforward terms are the baseline. Price differences between suppliers are small relative to the cost of a failed experiment, so the deciding factor should be documentation quality rather than the cheapest vial.

PeptideLabNova stocks the compound as a lyophilized research reagent with batch documentation; the MOTS-c product page shows the certificate information a laboratory should expect before ordering. A broader introduction to how research peptides are classified and supplied is on the site’s overview of what research peptides are, which is a useful companion read before the first order.

There is also a receiving-side practice that buyers should plan before the package lands. When the shipment arrives, confirm that the label names the ordered compound, that the batch number on the vial matches the certificate, that the seal is intact, and that the desiccant is dry. Each check belongs to the same documentation chain that begins with the certificate and ends with the methods section, and each takes less than a minute at the bench.

Common Sourcing and Handling Mistakes

Most problems with this reagent are not chemistry problems; they are sourcing problems. The most common mistake is buying on the basis of the listing name alone and discovering later that the supplied batch is a different salt form, a different peptide entirely, or a mirrored listing with no certificate. The second most common mistake is assuming that a purity percentage on a website is the same thing as a batch certificate; it is not, and only the certificate ties the numbers to the material in the vial.

The third mistake is storage complacency. A lyophilized vial that sits open on a bench absorbs humidity, and a reconstituted solution that is thawed and refrozen repeatedly becomes a different experimental material than the one documented on the certificate. The compound itself is stable enough in good conditions; the failures are almost always handling failures, which is why the reconstitution routine above is worth reading twice before material is opened.

A fourth mistake is documentation drift mid-experiment. A laboratory that verifies the certificate once at arrival, then stops recording batch numbers on tubes and worksheets, slowly loses the ability to connect results to material. By the time the paper is drafted, the link is gone, and the methods section has to describe the reagent without being able to point to the batch. Solutions should be labeled with the batch number on the day they are made, and the label should stay with the samples for the entire experiment, not just until the first plate is read.

Dose-Response Design and Assay Planning

A laboratory that orders the MOTS-c mitochondrial peptide for cell-culture work should plan a full concentration-response design rather than a single point. The literature reports effects across a range of concentrations, the sensitive window varies with the model, and a single dose gives no information about the shape of the relationship. Running five or six doses with proper replicates costs little extra in reagent terms — the peptide quantities involved are small — and it produces a curve that is far easier to defend than an isolated data point.

Design decisions worth making before the order lands include the top concentration, the dilution factor, and the vehicle control scheme. Because the MOTS-c mitochondrial peptide is supplied as a lyophilized solid that is reconstituted into an aqueous stock, the dose plan also has to account for the salt form stated on the certificate, since the counterion changes the mass-per-mole math that converts molar concentrations into solution volumes. Decide the stock concentration once, record it on the worksheet, and derive every working dilution from that single stock to keep the arithmetic consistent across the whole experiment.

Documentation Practices Across the Order Lifecycle

Documentation for the MOTS-c mitochondrial peptide should span the whole lifecycle of the reagent, not just the moment of purchase. At order time, the purchase record should name the compound, the batch, and the form. At receipt, the receiving log should record the vial condition and confirm the batch match. At reconstitution, the worksheet should record the solvent volume and date. At assay time, the plate records should reference the same batch number. Each of these steps is small, and each takes seconds when it happens, but together they create a chain that makes the methods section trivial to write and impossible to challenge on sourcing grounds.

One habit that laboratories new to the MOTS-c mitochondrial peptide miss is archiving certificates centrally rather than in inboxes or lab drawers. The cost of a central folder is negligible, and the benefit appears the first time a reviewer asks which batch produced a given result. It also makes vendor comparison honest: with a folder of batch certificates from several suppliers, a laboratory can compare purity distributions, identity statements, and documentation completeness on the same scale, which is a better basis for a sourcing decision than the price list.

Building a Defensible Methods Section

When the study is written up, the methods section should be able to stand on the documents alone. That means naming the compound exactly as the certificate names it, citing the batch number, stating the reported purity and the identity confirmation method, describing the reconstitution and storage steps in enough detail that another laboratory could repeat them, and naming the cell model and exposure conditions that motivated the design. None of that requires a paragraph of text; it requires a paper trail that was kept from the order to the assay.

Reviewers increasingly check material sourcing in peptide studies, and the difference between a complete and an incomplete methods section is usually whether the batch documentation was kept. Treat the certificate as part of the data set, because in a real sense it is: the identity, purity, and form statements on the paper are the only objective link between the published result and the material that produced it.

When writing the section, state the naming convention early — one sentence saying the compound is the short mitochondrial peptide known as MOTS-c and that the sequence shorthand and the full name refer to the same molecule. Then keep the rest of the write-up consistent with that statement. Consistency of naming looks like a small thing, but it is the fastest way to signal that the sourcing was deliberate, and it is the first thing a skeptical reviewer checks in a field where names are routinely mixed.

Final Checklist for Research Buyers

Before placing the order, running the assay, or writing the paper, a short checklist keeps the project defensible from start to finish:

• Confirm the peptide name, the sequence shorthand, and the catalog identifier all refer to the same molecule before ordering.
• Request the batch certificate before purchase and check HPLC purity, mass-spec identity, batch number, and stated form.
• Plan the reconstitution routine in advance: bacteriostatic water, wall-directed addition, gentle swirling, single-use aliquots.
• Record compound, batch, date, and concentration on every tube and worksheet.
• Keep the certificate with the purchase records and cross-reference the batch number in the final methods section.
• Verify the vial label, seal, and desiccant on arrival, and photograph anything that does not match the certificate.

The goal of this guide has been simple: to make buying this specialized reagent a documented, bench-ready process instead of a listing-name gamble. Between the primary literature, the certificate checks, and the handling routine described here, a laboratory can source the material rigorously and defend the choice in any methods section. For readers new to the category, the site’s overview of what research peptides are, linked in the sourcing section above, is the best first stop before the first order.

Frequently Asked Questions

What is the MOTS-c mitochondrial peptide?

MOTS-c is a short peptide derived from the mitochondrial genome, which is unusual because most research peptides are encoded in the nuclear genome. It is studied as a mitochondrial signaling molecule in cell-culture models, and it is supplied as a lyophilized research reagent with a batch certificate.

Where is the MOTS-c mitochondrial peptide studied?

The published work focuses mainly on cell-culture investigations of metabolic signaling, including stress-response models in muscle and liver cell lines. Interest in the peptide has grown as mitochondrial signaling has become a busier research topic, and a PubMed search returns the primary literature directly.

How do I verify the purity of a MOTS-c mitochondrial peptide vial?

Check the batch certificate: HPLC purity percentage for the exact batch, mass-spectrometry identity confirmation, and a batch number printed on the vial. Because the sequence is short, identity confirmation matters more than raw length claims, and independent lab reports can confirm a vendor’s documents.

How should the MOTS-c mitochondrial peptide be reconstituted?

Exactly like other lyophilized peptides: refrigerate the sealed vial, reconstitute with bacteriostatic water using a wall-directed technique, swirl rather than shake, refrigerate the solution, and aliquot for single-use tubes to avoid repeated freeze-thaw cycles.

Is the MOTS-c mitochondrial peptide related to SS-31?

Both are small peptides discussed in mitochondrial research, but they are different molecules with different sequences and different published literatures. Laboratories sometimes compare them; when they do, each compound needs its own vials, batches and records.

Research use only: The information above is a factual summary of product and literature context for laboratory research buyers. PeptideLabNova products are supplied exclusively for research purposes, are not intended for human consumption, and nothing in this article constitutes medical, veterinary, or clinical advice.